121results about How to "Improve dysfunction" patented technology

Techniques are provided for use in controlling rate-adaptive pacing within implantable medical devices such as pacemakers or implantable cardioverter-defibrillators (ICDs). In one example, a force-frequency relationship is determined for the heart of the patient, which is representative of the relationship between cardiac stimulation frequency and myocardial contractile force. To this end, various parameters are detected for use as surrogates for contractile force, including selected systolic pressure parameters and cardiogenic impedance parameters. Rate-adaptive pacing is then controlled based on the detected force-frequency relationship to, for example, deactivate rate-adaptive pacing if the slope and/or abscissa of the force-frequency relationship indicates significant contractility dysfunction within the patient. In other examples, rather than deactivating rate-adaptive pacing, control parameters are adjusted to render the rate-adaptive pacing less aggressive. In still other examples, trends in the slope and/or abscissa of the force-frequency relationship are monitored to detect contractility dysfunction and/or heart failure and titrate medications accordingly.

A method and apparatus for treatment of hypertension with electrostimulation of peripheral nerves. Treatment is performed by periodically stimulating a nerve such as a median nerve. Apparatus for stimulation is permanently implanted in the body. The nerve is stimulated by electric current applied to electrodes that are placed near the target nerve or the muscle innervated by the target nerve.

The invention defines interdependent biofactors and biomolecules, and clinically useful formulations that are comprised of them. The active agents are demonstrated to be complementary in their physiologic functions especially as these relate to the quenching of free radicals and to the support of endothelial physiology, the reduction of hyperinsulinemia and improvements in vascular health. The active components of the invention are selected for inclusion in precise combinations specifically because they improve these various conditions and physiological functions, and by so doing reduce a variety of risks associated with hearing loss and tinnitus. The resulting enhancement of general systemic vascular health, improvement in local VIIIth nerve vascular health, modulation of conditions surrounding blood fluid dynamics, the consequences of hyperinsulinemia, and improvements in free radical defenses, all reduce the potential for cochlear hair cell death and VIIIth nerve atrophy, and the hearing loss and possible deafness that accompany them.

A method for performing a medical procedure in an intestine of a patient is provided. The method comprises providing a system comprising: a catheter for insertion into the intestine, the catheter comprising: an elongate shaft comprising a distal portion; and a functional assembly positioned on the shaft distal portion and comprising at least one treatment element. The catheter is introduced into the patient, and target tissue is treated with the at least one treatment element. The target tissue comprises mucosal tissue of the small intestine, and the medical procedure can be configured to treat one or more diseases or disorders based on a measured physiologic parameter of the patient.

A computer-based method of determining a functional assessment of at least one organ having secretional or excretional functions, such as a liver or kidneys, of a human is disclosed. The method comprises processing a four-dimensional (4D) image data set of said human comprising data for an assessment of said organ function, wherein said 4D image data is acquired by an image modality; and wherein said processing said 4D image data comprises performing a deconvolutional analysis (DA) comprising a matrix inversion using singular value decomposition (SVD) based on said 4D image data.

To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance or ameliorate the pathosis, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant or, a fraction thereof containing the compound as an active ingredient.

The invention discloses healthcare food for comprehensively improving disorder of spleen and stomach and intestinal tract and preparation method of the healthcare food. The defects that the spleen and stomach and intestinal tract are not regarded as an organic integer to be comprehensively conditioned, the condition effect is not ideal, and the applicability is not strong in the prior art are overcome. The technical scheme is as follows: the food is characterized by comprising the following raw materials in parts by weight: 0.1-5 parts of galatooligosaccharide, 0.5-6 parts of fructo-oligose, 0.5-8 parts of polydextrose, 0.1-1.5 parts of dioscorea opposite extract, 0.1-2.5 parts of malt and 0.5-3 parts of red dates. The preparation method comprises the following steps: (1) taking the malt and red dates, removing impurities, cleaning, washing and drying the malt and red dates, and grinding into 60-80-mesh fine powder; (2) uniformly mixing the fine powder obtained in the step (1) with the galatooligosaccharide, the fructo-oligose, the polydextrose and the dioscorea opposite extract; (3) pelletizing the mixed fine powder by using edible alcohol with concentration of 90-95%; (4) sterilizing the particles for 1-1.5 hours at 60-75 DEG.C; and (5) screening the sterilized particles through a 60-80-mesh sieve, filling in a composite aluminum film bag to store so as to obtain the finished product.

The present invention provides a preventive or a remedy for penile erectile dysfunction, which promotes blood-flow in a penile sponge body over long time and thus induces erection while showing high safety without any adverse effect on a body as a whole, when externally administered to a penis. Use of a drug of the present invention enables to prevent or treat male penile erectile dysfunction and, at the same time, overcome a problem of female insertion impediment caused by increased resistance due to vaginal secretion disorder. Namely, a sexual life of patients (including aged persons) having coital dysfunction can be normalized and thus QOL can be improved.

The invention is: a natural active water-soluble protein and polypeptide and a preparation method thereof. Using selected natural protein-rich raw materials, through grinding and pulping, using a protein extractant to extract crude protein, using a solvent for simple degreasing, and then enzymatic fine degreasing and enzymatic fine decellulose to obtain refined protein pulp, and then Use end-capping agents to protect useful protein end groups, then use local acidifiers to locally acidify the long chain of proteins, then use acid protease for preliminary enzymatic hydrolysis, neutral protease for deep enzymatic hydrolysis, and timely detect the molecular weight, molecular weight distribution and amino acids of water-soluble proteins and polypeptides Content and other control indicators, when the control indicators reach the required value, stop the enzymatic hydrolysis reaction, then add deodorizing agent to remove odor, decolorizing agent to decolorize, filter and separate through filter, freeze or spray dry to obtain the finished product of natural active water-soluble protein and polypeptide .

The invention relates to a traditional Chinese medicine for treating chloasma; the invention is a medicament prepared by the following raw materials by weight proportion through a conventional method: 5-8g of angelica, 8-10g of safflower, 8-10g of figwort, 5-8g of radix bupleuri, 5-10g of trichosanthin, 8-10g of red paeonia, 5-10g of rhizoma anemarrhenae, 10-20g of radix astragali, 8-12g of fried atractylodes rhizome, 6-10g of prepared nutgrass galingale rhizome and 1.5-3g of liquorice. The invention has rapid curative effect, short treatment course, high cure rate, low cost but no toxic and side effects at all; through the clinical application of patients, the cure rate reach 95 percent and the total effective rate can reach over 98 percent. Furthermore, the invention has significant treatment effect for the patients with stain and irregular menstruation. .